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The broad-spectrum benzoxaborole antifungal AN2690 blocks protein synthesis by inhibiting leu-
cyl-tRNA synthetase (LeuRS) via a novel oxaborole tRNA trapping mechanism in the editing site.
Herein, one set of resistance mutations is at Asp487 outside the LeuRS hydrolytic editing pocket,
in a region of unknown function. It is located within a eukaryote/archaea speciﬁc insert I4, which
forms part of a cap over a benzoxaborole-AMP that is bound in the LeuRS CP1 domain editing active
site. Mutational and biochemical analysis at Asp487 identiﬁed a salt bridge between Asp487 and
Arg316 in the hinge region of the I4 cap of yeast LeuRS that is critical for tRNA deacylation. We
hypothesize that this electrostatic interaction stabilizes the cap during binding of the editing sub-
strate for hydrolysis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Aminoacyl-tRNA synthetases (AARSs) are essential to all organ-
isms and have been pursued as promising pharmaceutical drug
targets [1]. Pseudomonic acid (Mupirocin) has been used for years
as a topical antibiotic to selectively inhibit isoleucyl-tRNA synthe-
tase (IleRS) via interactions with its aminoacylation active site. Re-
cently, a novel benzoxaborole called AN2690 was discovered to
block protein synthesis in yeast by binding to the editing site of
cytoplasmic LeuRS [2].
Each of the AARSs establishes the genetic code via an aminoacy-
lation reaction that attaches a speciﬁc amino acid to its cognate
tRNA, which is then delivered to the ribosome. To enhance ﬁdelity,
about half of the AARSs have evolved ‘editing’ or ‘proofreading’
mechanisms [3]. A ‘post-transfer’ editing mechanism hydrolyzes
the misacylated tRNA to release free uncharged tRNA and amino
acid. This correction mechanism is carried out by AARSs that have
hydrolytic domains or by free-standing tRNA deacylases [4,5].
Alternatively, ‘pre-transfer’ editing clears misactivated amino-
acyl-adenylate [6].chemical Societies. Published by E
is).The class 1 AARS canonical core of LeuRS houses the synthetic
aminoacylation site. A discretely folded polypeptide insertion,
called the connective polypeptide 1 (CP1) [7] contains the hydro-
lytic editing active site [8]. The antifungal AN2690 forms an adduct
to tRNALeu in the editing pocket to trap the enzyme in a non-pro-
ductive conformation (Fig. 1). A series of AN2690-resistant muta-
tions were isolated within the CP1 domain of yeast LeuRS that
localized to the hydrolytic editing active site [2]. Here, we focused
on two resistance mutations at Asp487 that lie outside the hydro-
lytic editing active site in LeuRS, where AN2690 (Fig. 1) binds. This
resistance site is downstream of conserved motifs in the primary
sequence that deﬁne the editing pocket.
Sequence alignments show that Asp487 is located within an in-
sert called I4 that is speciﬁcally found in eukaryotes and archae,
but is absent in the bacteria (Fig. 1C). An X-ray crystal structure
of the CP1 domain from Candida albicans LeuRS suggests that the
I4 insert forms part of a cap over the hydrolytic active site [9].
When closed, the I4 cap in the C. albicans structure sequesters an
AN2690-benzoxaborole analog called AN3018 (Fig. 1) that is cova-
lently linked to AMP. In this case, the AMP portion of the bound
small molecule is proposed to mimic the 30 end of a tRNA molecule
that is bound in the editing site [9].
Since the benzoxaborole binds in the editing site where the
mischarged tRNA editing substrate binds in LeuRS [2,10], welsevier B.V. All rights reserved.
Fig. 1. Primary and tertiary structures of LeuRS I4 ‘cap’ insert within the CP1 editing domain. (A) Crystal structure of C. albicans cytoplasmic LeuRS CP1 domain in complex
with AN3018-AMP (orange) (PDB entry 2WFG) [9]. The I4 insert (Glu454 to Asn493 in C. albicans) is highlighted in blue with Gly490 (which corresponds to the Asp487 in
yeast cytoplasmic LeuRS) shown in red. Yellow balls denote ordered water molecules in the editing pocket. (B) Chemical structures of AN2690 and AN3018. (C) Multiple
sequence alignment of the I4 insert within the LeuRS CP1 domain. The blue line highlights the I4 insert. The Asp487 in yeast LeuRS is indicated in red and by the arrow. The
orange line indicates the putative ‘translocation’ peptide proposed in Escherichia coli LeuRS [14]. The residues boxed in orange within this peptide are proposed to impair
translocation. Abbreviations are: Thermus thermophilus (Tt), E. coli (Ec), S. cerevisiae cytoplasmic (Sc-c), C. albicans cytoplasmic (Ca-c) and P. horikoshii (Ph).
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impact hydrolytic editing. Biochemical analysis of mutations at
Asp487 showed that a negatively charged residue was essential
to hydrolytic editing activity. We hypothesize that Asp487 plays
a critical role in facilitating the I4 cap closure over the editing ac-
tive pocket during substrate binding. Our results support that elec-
trostatic interactions between Asp487 and an arginine residue
within the editing pocket facilitates the lid-like orientation of the
I4 cap to stabilize bound substrate and promote editing.
2. Materials and methods
Crude Saccharomyces cerevisiae tRNA was acquired from Sigma
Chemical Co. (St Louis, MO) and deacylated by incubation in
100 mM Tris, pH 8.5 at 37 C for 1 h. The concentration of charge-
able tRNALeu in crude (total) yeast tRNA was measured based on
the plateau or maximal charging levels using standard aminoacyla-
tion assays as described below to determine that 1 mg/mL crude
(total) tRNA contained 400 nM chargeable tRNALeu.
Mutations that are resistant to AN2690 were selected using the
haploid S. cerevisiae strain (ATCC 201388) via methods that have
been previously described [2]. Spontaneous ethylmethane sulfo-
nate (EMS)-induced resistant mutants were isolated from YPD agar
plates that contained concentrations of 2 lg/mL, 4 lg/mL, and
8 lg/mL AN2690.
Site directed mutagenesis was carried out via the polymerase
chain reaction (PCR). The plasmid p32YL-2-3 [10] encoding the
wild type S. cerevisiae cytoplasmic LeuRS was used as the template
to introduce the desired mutations to generate the plasmids
pJSycD487G, pJSycD487N, pJSycD487A, pJSycD487K, pJSycD487R
and pJSycD487E encoding the mutant D487G, D487N, D487A,
D487K, D487R and D487E LeuRS enzymes, respectively. Plasmids
pJSycD487G, pJSycD487N and pJSycD487A were then used as tem-
plates in separate PCR reactions to introduce a second T319A
mutation in each mutant protein. This created the plasmids
pJSycD487G/T319A, pJSycD487N/T319A and pJSycD487A/T319A,encoding the double mutant D487G/T319A, D487N/T319A and
D487A/T319A LeuRSs, respectively. Plasmid pJSycD487K was uti-
lized as the template to introduce the second mutation R316D or
R316E generating the mutant D487K/R316D or D487K/R316E
LeuRSs, respectively. Similarly, plasmid pJSycD487R was utilized
as the template to introduce the second mutation R316D or
R316E generating the mutant D487R/R316D or D487R/R316E
LeuRSs, respectively. The N-terminal six-histidine tagged wild type
and mutant yeast cytoplasmic LeuRSs were expressed in Esche-
richia coli strain Rosetta (DE3) (Novagen) and puriﬁed via metal
afﬁnity chromatography [10]. The ﬁnal protein concentration was
determined spectrophotometrically at 280 nm using an extinction
coefﬁcient of 155 310 M1 cm1, estimated by the ExPASy Protpa-
ram tool (http://ca.expasy.org/tools/protparam.html).
The aminoacylation reactions contained 60 mM 4-(2-hydroxy-
ethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.5, 30 mM
MgCl2, 30 mM KCl, 1 mM dithiothreitol (DTT), 4 mg/mL S. cerevisiae
crude tRNA, 21 lM [3H]-leucine (150 lCi/mL) and catalytic con-
centrations of enzyme. Misaminoacylation reactions were carried
out similarly, except that the reaction mixture contained higher
concentrations of 23.5 lM [3H]-isoleucine (150 lCi/mL) and 1 lM
enzyme. Each reaction was initiated with 4 mM ATP. At desired
time points, reaction aliquots of 10 lL were quenched and pro-
cessed as described previously [8]. Kinetic parameters for the
aminoacylation reaction were measured using 0.5 lM enzyme. A
relatively high enzyme concentration was used for the kinetic as-
says due to low activity of the yeast LeuRS enzyme at lower con-
centrations. A range of 0.1–100 mg/mL crude yeast tRNA (Sigma)
was used which corresponded to 0.05–40 lM tRNALeu. The ‘En-
zyme Kinetics analysis’ module of Sigma Plot (Systat Software,
Inc.) was used to calculate the kinetic parameters and error.
Crude tRNA from S. cerevisiae (8 mg/mL) was misaminoacylated
with isoleucine by incubating the following reaction mixture at
30 C for 3 h in 60 mM HEPES, pH 7.5, 30 mM MgCl2, 30 mM KCl,
1 mM DTT, 50 lM [14C]-isoleucine (15.9 lCi/mL) or 25 lM [3H]-
isoleucine (500 lCi/mL), 1–5 lM editing defective LeuRS and
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ously [8]. Deacylation reactions were carried out at pH 7.5 in
60 mM Tris or HEPES, 10 mM MgCl2, 10 mM KCl, and approxi-
mately 2 mg/mL [14C]-Ile-tRNALeu or [3H]-Ile-tRNALeu. The reac-
tions were initiated with 0.5 lM enzyme and reaction aliquots of
5 lL were quenched, processed, and analyzed as described above.
Inorganic pyrophosphate (PPi) exchange assays were carried out
with reaction mixtures containing 50 mM HEPES, pH 8.0, 10 mM
MgCl2, 10 mM KCl, 1 mM DTT, 1 mM [32P]-PPi (100 lCi/mL),
1 mM ATP, and 1 mM leucine or 10 mM isoleucine were initiated
with 1 lM enzyme. Aliquots of 2 lL at speciﬁc time points were
analyzed via thin-layer chromatography [8].Fig. 2. Norvaline sensitivity of AN2690 resistant mutations at Asp487. The parental
S. cerevisiae strain ATCC 201388 [2] is labeled wild type (WT). The mutations D487G
and D487N correspond to the S. cerevisiae resistant strains ANA325 and ANA359,
respectively. The ‘halo’ of cell death around the central well, which incorporates
20 lL of norvaline (40 mg/mL), indicates that the resistant mutants are editing
defective.
Table 1
Apparent kinetic parameters for tRNALeu aminoacylation.a
LeuRS KM (lM) kcat (s1) kcat/KM (lM1 s1)
Wild type 0.6 ± 0.05 0.4 ± 0.01 0.7 ± 0.05
D487G 0.7 ± 0.10 0.2 ± 0.06 0.3 ± 0.10
D487N 0.4 ± 0.06 0.1 ± 0.01 0.3 ± 0.01
D487A 3.5 ± 0.8 0.3 ± 0.1 0.1 ± 0.01
D487K 1.2 ± 0.2 0.2 ± 0.01 0.2 ± 0.06
D487R 2.7 ± 1.2 0.3 ± 0.1 0.1 ± 0.06
a tRNALeu concentrations were varied as described in Section 2.3. Results
The antifungal LeuRS inhibitor, AN2690 binds in the CP1 do-
main-based editing active site of LeuRS [2]. The boron atom of
AN2690 forms bonds with the cis-diol groups of the ribose ring
at the 30 end of tRNALeu to yield a tRNA-AN2690 adduct in the edit-
ing site of LeuRS [2] (Fig. 1). The AN2690-tRNA-protein complex
prevents enzyme turnover, ultimately leading to an arrest in pro-
tein synthesis.
In yeast LeuRS, spontaneous resistant mutations were isolated
in the presence of concentrations of AN2690 that were 4-, 8-,
and 16-fold of its 0.5 lg/mL minimal inhibitory concentration
(MIC) [2]. The mutants were dominant and showed an 8 to 64-fold
increase in the yeast MIC. As would be expected based on target
interactions, the mutant LeuRSs lacked resistance to several other
known antifungal agents including amphotericin B, cerulenin, itr-
aconazole, aculeacin A, terbinaﬁne, tunicamycin, ciclopirox, cyclo-
hexamide, and nikkomycin Z (data not shown).
Previously, AN2690 spontaneous-resistance mutants were
localized to the editing active site of yeast LeuRS, where AN2690
binds directly [2]. Herein, we focused on missense mutations to
Asp487 where mutants with a cytoplasmic LeuRS bearing a glycine
(D487G) or asparagine (D487N) substitution conferred an increase
in the MIC of AN2690 to 32 lg/mL compared to 0.5 lg/mL for the
wild-type strain. Because Asp487 is at a site that is distal to the
hydrolytic editing active site, its effect on editing or alternate
mechanisms of action on the target LeuRS were not clear. The
Asp487 site is separated from the primary sequence that deﬁnes
the editing pocket/AN2690 binding site and it is located in an in-
sert called I4 that is speciﬁc to the archaeal and eukaryotic en-
zymes (Fig. 1).
Comparison of the apo crystal structure of the isolated CP1 do-
main from C. albicans LeuRS and the co-crystal structure containing
AN3018, an analog of AN2690 (Fig. 1B) [9] suggests that the yeast/
archeal-speciﬁc I4 helix is ﬂexible and can close in a ‘cap’ like fashion
over the editing site that is bound to the benzoxaborale inhibitor.
The space enclosed over the editing pocket by this I4 ‘cap’ accommo-
dates both the substrate and aﬁxednetwork ofwatermolecules.We
hypothesized that Asp487 of the I4 insert orients the cap for sub-
strate binding and stabilization in the editing site. Halo assays that
incorporated 20 lL of norvaline (40 mg/mL) in the central well [2]
support that the LeuRS D487G and D487N are editing defective
resulting in norvaline toxicities (Fig. 2).
We re-created the AN2690 resistant mutations, D487G and
D487N, aswell as a D487Amutation in the yeast cytoplasmic LeuRS.
To test the importance of a charged polar side chain in the I4 insert,
we also replaced Asp487 with lysine, arginine and glutamic acid,
generating the positively chargedmutant D487K and D487R aswell
as the homologous mutant D487E LeuRSs, respectively. Leucine-
dependent PPi exchange assays showed that the resistant mutants,
D487G and D487N (Fig. S1A) as well as the positively charged
D487K andD487R LeuRSmutants (Fig. S1B) activate cognate leucinesimilar to the wild type enzyme. Based on its lowered plateau, the
D487A mutant LeuRS exhibited slightly reduced ATP formation
compared to the wild type enzyme (Fig. S1A).
We tested each yeast mutant LeuRS using commercially avail-
able crude yeast tRNA, since we previously determined that an
in vitro generated yeast tRNALeu transcript is a very poor substrate
for its cognate LeuRS [10]. We hypothesize that modiﬁcations are
critical in stabilizing the structure of yeast tRNALeu. Alternatively,
they may provide an important determinant for aminoacylation
by yeast LeuRS [11]. These mutant LeuRSs aminoacylate tRNALeu
(Fig. S1C, D) with approximately 2-fold reduction in kcat/KM values
(Table 1) as compared to the wild type enzyme. The decrease in the
kcat/KM for the D487A and the positively charged D487 mutant
LeuRSs is primarily due to an increase in KM (Table 1).
The Asp487 mutant LeuRSs were tested for their amino acid
editing activity with yeast crude tRNA that was misaminoacylated
with isoleucine using an editing-defective LeuRS. The AN2690-
resistant mutants, D487G, D487N and also the D487A mutant
exhibited signiﬁcantly reduced deacylation activity for Ile-tRNALeu
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pletely defective in hydrolyzing misacylated tRNA (Fig. 3B). Inter-
estingly however, a homologous substitution at Asp487 by
glutamic acid retains substantial editing activity (Fig. 3B). Also as
expected, the aminoacylation activities of the LeuRS Asp487 resis-
tance mutants were not inhibited by AN2690 (Fig. S2). The mech-
anism of action for AN2690 inhibition requires tRNALeu binding in
the editing active site for it to be trapped by the benzoxaborole.
The yeast cytoplasmic Asp487 LeuRS mutant editing deﬁcien-
cies resulted in low accumulations of mischarged Ile-tRNALeu in
misaminoacylation assays using crude yeast tRNA (Fig. S3A, B).
These mischarging plateaus are about 8-fold lower than a strong
mischarging LeuRS mutant, such as D419A (data not shown) which
substitutes a universally conserved residue in the editing pocket
that stabilizes the editing substrate via a hydrogen bond [10] How-
ever, these Asp487 LeuRS mutants exhibited similar activation of
isoleucine as compared to the wild type enzyme in isoleucine-
dependent PPi exchange assays (Fig. S3C, D). As would be expected,
the wild type yeast LeuRS did not mischarge the crude yeast tRNA
with isoleucine since LeuRS, like all other AARSs, is speciﬁc for its
cognate tRNA. Recognition of tRNALeu by LeuRS is facilitated by
speciﬁc determinants found within the tRNA [11] as well as by ter-
tiary structure formed between the D and TWC-arms of tRNA [12].
The yeast cytoplasmic enzyme is also unusual amongst the LeuRSs
in that it relies on the anticodon of tRNALeu for recognition [13].
Since a homologous substitution at Asp487 could restore the
enzyme’s hydrolytic activity, we wondered how this negative
charge that is outside the editing pocket contributed towards ami-
no acid editing. We scrutinized the X-ray crystal structure of the C.
albicans CP1 domain in complex with the benzoxaborale AN3018
[9]. The C. albicans LeuRS CP1 domain has a glycine residue
(Gly490) at the position comparable to Asp487 in S. cerevisiae
LeuRS (Fig. 1C). Ironically, a glycine at this site renders the yeast
LeuRS enzyme resistant to AN2690. Nevertheless, we relied on
the AN3018-bound C. albicans LeuRS structure as an opportunity
to guide our investigation into the structure-function role of
Asp487 in editing by yeast LeuRS.Fig. 3. Isoleucine editing activities of AN2690-resistant and charged Asp487
mutants of LeuRS. Deacylation reactions included approximately 2 mg/ml [14C]-
Ile-tRNAleu and 0.5 lM enzyme. Symbols are: wild type (j), D487G (N), D487N (.),
D487A (), D487K (h), D487R (e), D487E (D) and no enzyme (). Error bars for
each time point are a result of each reaction repeated in triplicate.When the I4 cap is closed over the AN3018-AMP bound editing
pocket in the X-ray crystal structure of the C. albicans LeuRS CP1
domain, the a-carbon of Gly490 is in close proximity (4 Å) to
the guanidinium group of the arginine at position 318 (Fig. 4A).
We identiﬁed Arg316 in S. cerevisiae LeuRS, (corresponding to
Arg318 of C. albicans LeuRS in the primary sequence) and hypoth-
esized that it was also located within or near the editing pocket.
Interestingly, R316I has been reported to be resistant to AN2690
in S. cerevisiae [2]. Although the yeast LeuRS Asp487 has a longer
side chain than the Gly 490 found in C. albicans LeuRS that could
place it closer than 4 Å to the arginine, we wondered if local rear-
rangements within the dynamic and diverse structures might
accommodate a salt bridge between Asp487 and Arg316 in the
yeast enzyme. If Asp487 at the base of the I4 cap forms an electro-
static salt-bridge with Arg316 of the yeast LeuRS editing pocket,
then we postulated that it could stabilize closure of the I4 cap to
sequester the bound substrate in the editing pocket.Fig. 4. Putative electrostatic interaction between the I4 insert and the editing
pocket of fungal cytoplasmic LeuRS. (A) Crystal structure of C. albicans cytoplasmic
LeuRS CP1 domain in complex with AN3018-AMP (PDB entry 2WFG) [9],
highlighting the I4 insert (blue), Gly490 in the I4 insert and Arg318 in the editing
pocket (analogous to Asp487 and Arg316, respectively in yeast LeuRS). (B)-(C)
Hydrolytic editing activities of single charged Asp487 mutants and Asp487/Arg316
double mutants. Deacylation reactions included approximately 2 mg/ml [14C]-Ile-
tRNAleu and 0.5 lM enzyme. Symbols are: wild type (j), D487K (h), D487R (e),
D487K/R316D and D487R/R316D (o), D487K/R316E and D487R/R316E (d) and no
enzyme (). Error bars for each time point are a result of each reaction repeated in
triplicate.
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Asp487 and Arg316 to construct the double mutants D487K/
R316D, D487K/R316E and D487R/R316D, D487R/R316E. The
D487K/R316D double mutant rescued hydrolytic activity of the
editing-defective positively-charged D487K mutant to levels that
were close to the wild type enzyme (Fig. 4B). The D487K/R316E
double mutant did not recover any hydrolytic editing activity
(Fig. 4B). We also observed that the double mutants D487R/
R316D and D487R/R316E did not rescue hydrolytic editing of the
editing-defective D487R mutant LeuRS (Fig. 4C). This suggests that
the longer side chains of glutamic acid and arginine may juxtapose
the residues too close to form an effective electrostatic interaction.
In lieu of an aspartate corresponding to position 487 in C. albicans
LeuRS, (Fig. 1C), the enzyme may depend on alternate residues to
form an electrostatic bridge. It is possible that Glu489, which
neighbors Gly490 (Fig. 1C), could form a salt bridge with Arg318.
Post-transfer editing is dependent on an intra-enzyme translo-
cation event that moves the tRNA between the main body and the
CP1 domain that are respectively responsible for aminoacylation
and editing. Mutations in the E. coli LeuRS ‘translocation peptide’
(Fig. 1C) appear to cause the mischarged tRNA to bypass the edit-
ing active site [14]. The eukaryotic LeuRSs lack this bacterial LeuRS
translocation peptide. However, in a primary sequence alignment,
Asp487 of the yeast cytoplasmic LeuRS is upstream to the N-termi-
nus of the site that would correspond to the E. coli LeuRS translo-
cation peptide. We wondered if the Asp487 region of the I4 cap
could facilitate tRNA translocation via a distinct mechanism. Previ-
ously, to test for disruptions in translocation, we relied on a con-
served threonine in E. coli LeuRS (Thr252) which is an amino acid
speciﬁcity determinant in the editing pocket that blocks leucine
from binding [8]. When mutated to alanine, loss of speciﬁcity con-
fers deacylation of Leu-tRNALeu, resulting in a phenotype of weak
charging activity for the T252A mutant LeuRS. Disruption of trans-
location would restore Leu-tRNALeu accumulation in the LeuRS
mutant.
Mutation of the threonine speciﬁcity determinant in yeast
LeuRS (Thr319) also results in low charging activity (Fig. 5). We
combined each of the resistant mutations, D487G and D487N, with
the editing site mutation T319A that uncouples speciﬁcity in the
editing site of yeast LeuRS, resulting in the double mutants
D487G/T319A and D487N/T319A, respectively. The Asp487 double
mutants rescued aminoacylation of the T319A mutant, resulting in
accumulation of Leu-tRNALeu up to wild type levels (Fig. 5). In this
case, it is possible that the charged 30 end of tRNALeu may not be
stably binding at the editing pocket or alternatively, has reduced
access to the editing site. We determined that the hydrolytic edit-
ing activity of the Asp487/Thr319 double mutants was signiﬁcantlyFig. 5. Rescue of aminoacylation of editing site mutation (T319A) by Asp487 LeuRS
mutants. Reactions consisted of 4 mg/ml S. cerevisiae crude tRNA, 0.5 lM enzyme
and 22 lM [3H]-leucine (150 lCi/ml) and were initiated with 4 mM ATP. Symbols
are: wild type (j), D487G/T319A (N), D487N/T319A (.), D487A/T319A (), T319A
(d) and no enzyme (). Error bars for respective time points represent each
reaction repeated in triplicate.decreased for the correctly charged product Leu-tRNALeu (Fig. S4A)
as well as the mischarged product Ile-tRNALeu (Fig. S4B) in compar-
ison to the single T319A mutant. These results suggest that muta-
tion of Asp487 destabilizes binding of the 30 end of the tRNA in the
editing pocket of the CP1 domain, rather than disrupting a tRNA
translocation mechanism.4. Discussion
The AARS family of enzymes by virtue of their essentiality and
diversity, have been a focus of drug discovery to identify new anti-
microbial agents. A traditional strategy has been to ﬁnd com-
pounds that selectively mimic the pathogen AARS substrates,
intermediates and transition state analogs, while sparing the hu-
man counterpart [1]. By screening libraries of synthetic boron-con-
taining small molecules, a new class of antifungals, the
benzoxaboroles, were discovered [15]. These antifungal benzoxab-
oroles inhibited LeuRS in a novel way by binding in the editing
pocket of the CP1 domain and trapping the tRNA in the editing con-
formation via an adduct with the cis-diols of the terminal nucleo-
tide [2,9].
Isolation of spontaneous and EMS-generated resistant mutants
to AN2690 have been reported within the editing pocket of LeuRS
[2], where the drug interacts directlywith the enzyme. Each of these
resistant mutants is editing defective in norvaline-dependent com-
plementation assays [2]. Herein,we characterized resistantmutants
D487G and D487N, which lie outside the editing active site. The C.
albicans and yeast cytoplasmic CP1 domain have acquired species-
speciﬁc peripheral insertions, one of which (I4) appears to form a
cap over the bound editing substrate (Fig. 1A). The Asp487 lieswith-
in the I4 peripheral insert. The crystal structure of the C. albicans CP1
domain shows that a networkofwatermolecules, aswell as the edit-
ing substrate, are sequestered within the space enclosed by the I4
cap over the editing pocket [9]. We hypothesize that Asp487 in the
species-speciﬁc I4 insert of the yeast LeuRS could bemechanistically
important to the cap’s hinge motion.
Resistance mutations highlighted that this I4 insert may be idi-
osyncratic, albeit an essential component of the editing mecha-
nism in LeuRS for lower eukaryotes. Mutations at Asp487 in
yeast LeuRS directly impact editing with minimal effects on amino-
acylation. Charge reversals at Asp487 completely destabilize the
editing activity. We scrutinized the available crystal structure
information to identify a plausible electrostatic salt bridge interac-
tion between Asp487 at the base of the I4 cap and Arg316 in the
editing pocket. Signiﬁcantly, a double mutation to reverse these
charges rescued editing activity of the D487K LeuRS mutant, which
suggests that the salt bridge was restored.
There are relatively few synthetase-tRNA contacts in the editing
complex compared to the aminoacylation complex [16]. In addi-
tion, the yeast LeuRS active site has been suggested to be more
open and accessible to water compared to its bacterial counterpart
that lacks the I4 insert. The I4 cap and this salt bridge between the
cap and the editing active site could stabilize substrate and inhib-
itor binding in a more open editing site, as well as orient enclosed
water molecules. Ultimately, AN2690 crosslinks to the tRNA in the
editing site resulting in a long half-life [2]. Although the ﬁt of the
AMP-benzoxaborole adduct in the editing pocket of LeuRS is com-
plementary, only a few hydrogen bonds within the LeuRS editing
active site stabilize it [2]. The AMP-benzoxaborole adduct is super-
imposable with a post-transfer editing substrate analog [2]. It also
directly contacts the universally conserved aspartic acid residue
(Asp419 in yeast LeuRS) in the editing active site that stabilizes
the post-transfer editing substrate via a hydrogen bond with the
a-amino group of the amino acid. However, the benzoxaborole ad-
duct lacks a key site analogous to the amino group of an aminoacy-
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and critically stabilize the bound editing substrate by providing or
orienting either direct or water-mediated contacts between the en-
zyme and the substrate.
We hypothesize that, in the Asp487 mutants, stabilization of
the charged 30 end of the tRNA is compromised. De-stabilization
of the bound substrate (the inhibitor or the charged 30 end of the
tRNA) at the editing site would also, at least in part, explain the
resistance of D487G and D487N to AN2690, which binds in the
editing pocket. We propose that Asp487, located within the I4 in-
sert, is instrumental in inducing segmental ﬂexibility of the I4 in-
sert and enables the cap to sequester the mischarged tRNA
substrate and/or AN2690.
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